# Coloplast to acquire Kerecis for up to USD 1.3 billion

Coloplast signed an agreement to acquire Kerecis, a company in the biologics wound care segment, for up to USD 1.3 billion, with an upfront cash payment of USD 1.2 billion. Kerecis develops wound care products based on fish skin.

- Type: Acquisition
- Announced: 2024-01-31
- Value: $1.30B
- Status: announced
- Products: biologics wound care products, fish skin-based wound dressings
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Coloplast](https://endata.com/companies/15184.md) (acquirer)
- [Kerecis](https://endata.com/companies/71300.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/coloplast-announces-agreement-to-acquire-kerecis-and-raises-long-term-growth-expectations), 2024-01-31: "We’re excited to join the Coloplast family and have their support in becoming the world leader in tissue regeneration."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.